193 related articles for article (PubMed ID: 22980591)
1. Clinical significance of elevated alpha-foetoprotein (AFP) in patients with chronic hepatitis C without hepatocellular carcinoma in upper EGYPT.
Kobeisy MA; Morsy KH; Galal M; Sayed SK; Ashmawy MM; Mohammad FM
Arab J Gastroenterol; 2012 Jun; 13(2):49-53. PubMed ID: 22980591
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of alpha-fetoprotein in chronic hepatitis C.
Tai WC; Hu TH; Wang JH; Hung CH; Lu SN; Changchien CS; Lee CM
J Formos Med Assoc; 2009 Mar; 108(3):210-8. PubMed ID: 19293036
[TBL] [Abstract][Full Text] [Related]
3. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
Omran MM; Farid K; Emran TM; Attallah AA
Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.
Bruce MG; Bruden D; McMahon BJ; Christensen C; Homan C; Sullivan D; Deubner H; Williams J; Livingston SE; Gretch D
J Viral Hepat; 2008 Mar; 15(3):179-87. PubMed ID: 18233991
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma.
Chen CH; Lin ST; Kuo CL; Nien CK
Hepatogastroenterology; 2008; 55(85):1423-7. PubMed ID: 18795704
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma.
Hu KQ; Kyulo NL; Lim N; Elhazin B; Hillebrand DJ; Bock T
Am J Gastroenterol; 2004 May; 99(5):860-5. PubMed ID: 15128351
[TBL] [Abstract][Full Text] [Related]
7. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
8. Clinical, biochemical and pathological profiles of 5464 Egyptian chronic hepatitis C-infected patients.
Mabrouk M; El-Raziky M; Zayed N; Salama R; El-Akel W; Awad T; El Beshlawy M; Esmat G
Hepatogastroenterology; 2013 Oct; 60(127):1731-5. PubMed ID: 24634943
[TBL] [Abstract][Full Text] [Related]
9. Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.
El Raziky M; Attia D; El Akel W; Shaker O; Khatab H; Abdo S; Elsharkawy A; Esmat G
Arab J Gastroenterol; 2013 Sep; 14(3):94-8. PubMed ID: 24206736
[TBL] [Abstract][Full Text] [Related]
10. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection.
Pohl A; Behling C; Oliver D; Kilani M; Monson P; Hassanein T
Am J Gastroenterol; 2001 Nov; 96(11):3142-6. PubMed ID: 11721762
[TBL] [Abstract][Full Text] [Related]
11. Clinical presentation of chronic hepatitis C in patients with end-stage renal disease and on hemodialysis versus those with normal renal function.
Hu KQ; Lee SM; Hu SX; Xia VW; Hillebrand DJ; Kyulo NL
Am J Gastroenterol; 2005 Sep; 100(9):2010-8. PubMed ID: 16128946
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C genotype 4 with normal transaminases: correlation with fibrosis and response to treatment, a cohort Egyptian study of 4277 patients.
Abdel-Rahman M; Saad Y; El-Raziky M; Zayed N; El-Akel W; Said M; El-Beshlawy M; Esmat G
Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):479-84. PubMed ID: 23540379
[TBL] [Abstract][Full Text] [Related]
13. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
14. Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels.
Cheong JY; Kim DJ; Hwang SG; Yang JM; Kim YB; Park YN; Cho SW
Liver Int; 2011 Oct; 31(9):1352-8. PubMed ID: 21745311
[TBL] [Abstract][Full Text] [Related]
15. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis.
Sterling RK; Jeffers L; Gordon F; Sherman M; Venook AP; Reddy KR; Satomura S; Schwartz ME
Am J Gastroenterol; 2007 Oct; 102(10):2196-205. PubMed ID: 17617202
[TBL] [Abstract][Full Text] [Related]
17. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations.
Tseng PL; Wang JH; Hung CH; Tung HD; Chen TM; Huang WS; Liu SL; Hu TH; Lee CM; Lu SN
Kaohsiung J Med Sci; 2013 Jul; 29(7):385-95. PubMed ID: 23768703
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum α-fetoprotein levels in patients with chronic hepatitis C virus genotype 4: not the end of the story.
Abdel-Razik A; Mousa N; Abdel-Aziz M; Elhelaly R; Elzehery R; Zalata K; Elkashef W; Fouda O; Awad M; Hafez M; Eldars W
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):313-22. PubMed ID: 26618566
[TBL] [Abstract][Full Text] [Related]
20. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
Huo TI; Hsia CY; Chu CJ; Huang YH; Lui WY; Wu JC; Lee PC; Chi CW; Lee SD
J Surg Oncol; 2007 Jun; 95(8):645-51. PubMed ID: 17530668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
